secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2026-07-23T20:25:51+00:00
Accession:  0001193125-26-314167
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImageneBio appoints Yanina Grant-Huerta as CFO; CMO Benjamin Porter-Brown transitions to consulting role
--------------------------------------------------------------------------------

- Yanina Grant-Huerta appointed CFO effective July 20, 2026; base salary $450,000, target bonus 40%, equity grants of 65,000 RSUs and 95,000 options.
- Benjamin Porter-Brown, CMO, will transition from full-time to consulting role effective July 24, 2026; will serve as strategic advisor.
- Grant-Huerta previously served as Chief Accounting Officer at Atara Biotherapeutics (ATRA) from March 2025 to July 2026.
- Grant-Huerta's equity awards vest over four years; 25% on first anniversary, remainder monthly/quarterly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312526314167/0001193125-26-314167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312526314167/d143178d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-314167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer